Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions

Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions

Source: 
BioSpectrum Asia
snippet: 

US-based ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of innovative medical devices, and Japan's Otsuka Pharmaceutical Factory, Inc. (OPF), global IV solutions manufacturing subsidiary of Otsuka Holdings Co., have together announced the creation of a joint venture to provide additional supply chain resiliency and innovation to the North American IV solutions market.